Janus Henderson Group plc 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-10 4:06 pm Sale | 2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | JANUS HENDERSON GROUP PLC JHG | 5,483,164 8.500% | -789,518 (-12.59%) | Filing |
| 2021-10-12 12:47 pm Purchase | 2021-09-30 | 13G | Global Blood Therapeutics, Inc. GBT | JANUS HENDERSON GROUP PLC JHG | 6,272,682 10.100% | 305,820 (+5.13%) | Filing |
| 2021-02-12 3:25 pm Purchase | 2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT | JANUS HENDERSON GROUP PLC JHG | 5,966,862 9.700% | 3,443,594 (+136.47%) | Filing |